The Taub Foundation Grants Program for Myelodysplastic Syndromes (MDS) Research was created to support high-impact, innovative, translational research to understand the underlying causes of MDS and to advance its treatment and prevention.
Innovative studies with transformative potential to elucidate MDS etiology and to develop new treatments are particularly encouraged. Proposals focused on the progression of MDS to AML are not within the scope of this funding.
The Taub Program supports independent investigators at all stages of their careers. To promote the expansion of the MDS research field collaborative efforts and proposals from young investigators and those from non-MDS fields are encourage to apply.
Application Deadline: Friday, May 19, 2017, 12:00 Noon, U.S. EDT
Award Amount: $600,000 over three years
Funding Period: December 15, 2017 - December 14, 2020
- Applicants must hold a Ph.D., M.D., M.D./Ph.D., or equivalent degree, and a faculty appointment at a non-profit academic, medical, or research institution in the United States.
- Applicants must be independent investigators with institutional support and their own laboratory.
- Applicants may not have funding support for a similar project.
- United States citizenship is not required; visa documentation is not required.